TAAV launches new corporate brand as a reflection of its transformation
/PRNewswire/ -- TAAV Biomanufacturing Solutions S.L.U., a wholly owned subsidiary of Asklepios Biopharmaceuticals (AskBio) and Bayer AG, today presents a new...
Stay updated with breaking news from Biomanufacturing Solutions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- TAAV Biomanufacturing Solutions S.L.U., a wholly owned subsidiary of Asklepios Biopharmaceuticals (AskBio) and Bayer AG, today presents a new...
Toronto, ON (PRWEB) March 16, 2023 -- The gene therapy clinical pipeline continues to be in a growth phase, with over 2,000 therapies in development globally,
/PRNewswire/ -- TAAV Biomanufacturing Solutions, S.L. (TAAV), an independently operated wholly-owned subsidiary of Asklepios BioPharmaceutical, Inc. (AskBio),...
Synthetic DNA material to be used in upcoming approved Huntington's disease study in France may be key to scaling gene therapy production